Stimulation of angiotensin II type 2 receptor attenuates organ injury in rats with polymicrobial sepsis

Chih-Chin Shih1, Shiu-Jen Chen2, Wen-Kuei Chang3,4

  • 1Department of Pharmacology, National Defense Medical Center, Taipei, Taiwan, ROC.

Abstract

Insights

Stimulating angiotensin II-type 2 receptors (AT2R) with CGP42112 improved survival in septic rats. This treatment reduced inflammation and organ damage, suggesting AT2R stimulation is a promising sepsis therapy.

Area of Science:

  • Cardiovascular Biology
  • Inflammation and Immunology
  • Renal Physiology

Background:

  • Sepsis pathogenesis involves inflammation and oxidative stress, leading to organ damage.
  • Angiotensin-(1-7) via Mas and angiotensin II-type 2 receptors (AT2R) may protect against sepsis-induced organ dysfunction.
  • The specific role of AT2R in sepsis-related inflammation and oxidative stress remains unclear.

Purpose of the Study:

  • To investigate the modulatory effects of AT2R stimulation on inflammation and oxidative stress in a rat model of polymicrobial sepsis.
  • To elucidate the molecular mechanisms underlying AT2R's protective actions in sepsis.

Main Methods:

  • Male Wistar rats underwent cecal ligation and puncture (CLP) or sham surgery.
  • Rats received intravenous saline or CGP42112 (AT2R agonist) 3 hours post-surgery.
  • Hemodynamics, biochemical markers, chemokine/nitric oxide levels, and organ histology were assessed over 24 hours.

Main Results:

  • CLP induced hypotension, hypoglycemia, and organ injury, evidenced by altered biochemical and histological parameters.
  • CGP42112 treatment attenuated these sepsis-induced effects.
  • CGP42112 reduced plasma chemokines and nitric oxide, decreased liver inducible nitric oxide synthase and nuclear factor-kappaB expression, and improved survival rates (50% vs. 20% at 24h).

Conclusions:

  • AT2R stimulation with CGP42112 demonstrated significant protective effects in a rat model of sepsis.
  • These benefits are likely mediated by anti-inflammatory actions.
  • Targeting AT2R represents a promising therapeutic strategy for managing sepsis.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
479
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
731
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
40